127 related articles for article (PubMed ID: 38364650)
1. Integrated bioinformatics approaches and expression assays identified new markers in pituitary adenomas.
Motlagh PE; Jamali E; Karimi N; Eslami S; Sharifi G; Ghafouri-Fard S
Pathol Res Pract; 2024 Mar; 255():155193. PubMed ID: 38364650
[TBL] [Abstract][Full Text] [Related]
2. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas.
Butz H; Likó I; Czirják S; Igaz P; Korbonits M; Rácz K; Patócs A
Pituitary; 2011 Jun; 14(2):112-24. PubMed ID: 21063788
[TBL] [Abstract][Full Text] [Related]
4. A bioinformatics-based approach and expression assay for identification of dysregulated genes in pituitary adenoma.
Jamali E; Hashemnejad MA; Askari A; Shomali H; Eslami S; Akbari Dilmaghani N; Sharifi G; Bahranian A; Ghafouri-Fard S
Pathol Res Pract; 2024 Jan; 253():155006. PubMed ID: 38056134
[TBL] [Abstract][Full Text] [Related]
5. BRD4 as a therapeutic target for nonfunctioning and growth hormone pituitary adenoma.
Shi C; Ye Z; Han J; Ye X; Lu W; Ji C; Li Z; Ma Z; Zhang Q; Zhang Y; He W; Chen Z; Cao X; Shou X; Zhou X; Wang Y; Zhang Z; Li Y; Ye H; He M; Chen H; Cheng H; Sun J; Cai J; Huang C; Ye F; Luo C; Zhou B; Ding H; Zhao Y
Neuro Oncol; 2020 Aug; 22(8):1114-1125. PubMed ID: 32246150
[TBL] [Abstract][Full Text] [Related]
6. Gene and protein expression in pituitary corticotroph adenomas: a systematic review of the literature.
Seltzer J; Ashton CE; Scotton TC; Pangal D; Carmichael JD; Zada G
Neurosurg Focus; 2015 Feb; 38(2):E17. PubMed ID: 25639319
[TBL] [Abstract][Full Text] [Related]
7. Study of LncRNA BANCR Expression in Tumor Tissues and Adjacent Normal Tissues in Gastric Cancer Patients.
Nikanfar R; Dabbaghi R; Rajabi A; Hashemzadeh S; Baradaran B; Teimourian S; Safaralizadeh R
Adv Biomed Res; 2023; 12():186. PubMed ID: 37694252
[TBL] [Abstract][Full Text] [Related]
8. Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas.
Butz H; Németh K; Czenke D; Likó I; Czirják S; Zivkovic V; Baghy K; Korbonits M; Kovalszky I; Igaz P; Rácz K; Patócs A
Pathol Oncol Res; 2017 Jul; 23(3):633-641. PubMed ID: 28004354
[TBL] [Abstract][Full Text] [Related]
9. Expression of CRABP1, GRP, and RERG mRNA in clinically non-functioning and functioning pituitary adenomas.
Chile T; Corrêa-Giannella ML; Fortes MA; Bronstein MD; Cunha-Neto MB; Giannella-Neto D; Giorgi RR
J Endocrinol Invest; 2011 Sep; 34(8):e214-8. PubMed ID: 21270509
[TBL] [Abstract][Full Text] [Related]
10. lncRNA BANCR suppresses cell viability and invasion and promotes apoptosis in non-small-cell lung cancer cells in vitro and in vivo.
Yang L; Liu G
Cancer Manag Res; 2019; 11():3565-3574. PubMed ID: 31114383
[No Abstract] [Full Text] [Related]
11. lncRNA LINC-PINT is downregulated in melanoma and regulates cell proliferation by downregulating lncRNA BANCR.
Huang Q; Zhang D; Diao Q; Lin M
Oncol Lett; 2019 Sep; 18(3):2917-2922. PubMed ID: 31452772
[TBL] [Abstract][Full Text] [Related]
12. Construction of lncRNA regulatory networks reveal the key lncRNAs associated with Pituitary adenomas progression.
Xue YH; Ge YQ
Math Biosci Eng; 2020 Jan; 17(3):2138-2149. PubMed ID: 32233527
[TBL] [Abstract][Full Text] [Related]
13. Potential biomarkers and lncRNA-mRNA regulatory networks in invasive growth hormone-secreting pituitary adenomas.
Yin H; Zheng X; Tang X; Zang Z; Li B; He S; Shen R; Yang H; Li S
J Endocrinol Invest; 2021 Sep; 44(9):1947-1959. PubMed ID: 33559847
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the expression of necroptosis pathway mediators and its association with tumor characteristics in functional and non-functional pituitary adenomas.
Khamseh ME; Sheikhi A; Shahsavari Z; Ghorbani M; Akbari H; Imani M; Panahi M; Alimohammadi A; Ameri M; Nazem S; Salimi V; Tavakoli-Yaraki M
BMC Endocr Disord; 2022 Jan; 22(1):1. PubMed ID: 34983494
[TBL] [Abstract][Full Text] [Related]
15. Role of lncRNA BANCR in Human Cancers: An Updated Review.
Hussen BM; Azimi T; Abak A; Hidayat HJ; Taheri M; Ghafouri-Fard S
Front Cell Dev Biol; 2021; 9():689992. PubMed ID: 34409032
[TBL] [Abstract][Full Text] [Related]
16. The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas.
Dai C; Liang S; Sun B; Kang J
Front Endocrinol (Lausanne); 2020; 11():608422. PubMed ID: 33362722
[TBL] [Abstract][Full Text] [Related]
17. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
[TBL] [Abstract][Full Text] [Related]
18. Title Expression of FOXO3 and MAPK1 Genes in Patients with Benign Salivary Gland Tumors.
Kolary-Siekierska K; Niewiadomski P; Namieciński W; Miłoński J
J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202222
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
[TBL] [Abstract][Full Text] [Related]
20. N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.
Vaitkiene P; Valiulyte I; Glebauskiene B; Liutkeviciene R
Diagn Pathol; 2017 Apr; 12(1):33. PubMed ID: 28390436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
